Searched for
ORAL SOLID DOSAGES
HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...- Biocon inaugurates first manufacturing facility in USBiocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Fo...
- Supriya Lifescience expects to double revenue to Rs 1,000 crore in next 3 yearsSupriya Lifescience aims to double revenue to Rs 1,000 crore by venturing into higher-margin niche segments. Led by Satish Wagh, it is expa...
- Biocon acquires Eywa Pharma's US-based plant for $7.7 millionBiocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...
- USFDA issues Form-483 with two observations for Lupin's Nagpur plantLupin's Nagpur facility has received two observations from the USFDA through Form-483 due to violations of the Food Drug and Cosmetic (FD&C...
- WEF recognises DRL's Bachupally plant, Cipla's Indore OSD unit as part of Global Lighthouse NetworkA press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...
- Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 croreSuven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...
- Piramal Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in USThe site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), it added.
- Lupin gets 2 observations from USFDA for Nagpur facility"The inspection closed with two 483 observations," Lupin said.
- Lupin gets EIR from USFDA for Nagpur facilityUSFDA conducted the inspection between August 5-8, 2019, Lupin said in a filing to the BSE.
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...
- Cadila Healthcare gets EIR for Ahmedabad plant from USFDA"The company's Oral Solid Dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) f...
- Indoco Remedies shares soar 12% on USFDA nod for Goa plantThe stock soared 11 per cent to settle at Rs 296.75 on BSE. During the day, it jumped 17.44 per cent to Rs 314.
- Indoco Remedies gets USFDA nod for Goa solid dosages plantIndoco Remedies today said it has received an approval from the US Food and Drug Administration (USFDA) for its solid dosages manufacturing...
- USFDA finds company's SEZ Indore unit acceptable: Ipca LabsThis will enable the company to commercialise oral solid dosage formulations in the US market from this manufacturing facility.
- Vivimed acquires Actavis Pharma's facility for Rs 122 croreVivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.
- Arvind Remedies Q4 net profit at Rs 12.41 croreThe company's net sales for the quarter stood at Rs 173.98 crore, registering a growth of 65 per cent, as against Rs 105.6 crore in year-ag...
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Zydus Cadila's Baddi plant gets USFDA approvalZydus Cadila today said the USFDA has given the green signal for commencement of drug supplies to the US from its plant at Himachal Pradesh.
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...
Load More
